CB25235-1A - 0x0000000000003ABF

Males & Females of Non-Childbearing Potential

* Stipend may pay up to reflected amount.
Start Date: 
February 28, 2019 - 12:00pm
End Date: 
June 21, 2019 - 10:30am

Study Details

Study Number: CB25235
Group Number: 1A
Study Requirement: Healthy Normal Male and Female
Stipend: up to £ 4,213

Study Criteria

Age: 18 - 50
BMI: 0 - 34.9
Weight Restriction: minimum weight 45 lbs

Study Information

Indication: This investigational medication is being developed to treat Cystic Fibrosis.
Route of Administration: Inhalation
Blood Draws: 0

Study Schedule

Schedule Type: Short stays with returns
Study Length: One - 2 Night Stay, One - 1 Night Stay & 9 Returns

Screening Dates:

Event Day Event Date Site
No search results

Doctor Exam Dates:

Event Day Event Date Site
No search results

Study Dates:

Event Type Start Day Start Date End Day End Date Phase Site
Check-In Thursday Feb 28 2019 12:00PM Saturday Mar 2 2019 8:30AM 1 Belfast
Return Monday Mar 4 2019 7:30AM Monday Mar 4 2019 4:30PM 1 Belfast
Return Friday Mar 8 2019 7:30AM Friday Mar 8 2019 4:30PM 1 Belfast
Return Friday Mar 15 2019 7:30AM Friday Mar 15 2019 4:30PM 1 Belfast
Check-In Friday Mar 22 2019 6:00AM Saturday Mar 23 2019 12:00PM 1 Belfast
Return Friday Mar 29 2019 7:30AM Friday Mar 29 2019 9:30AM 1 Belfast
Return Friday Apr 5 2019 8:30AM Friday Apr 5 2019 9:30AM 1 Belfast
Return Friday Apr 19 2019 8:30AM Friday Apr 19 2019 9:30AM 1 Belfast
Return Friday May 10 2019 8:30AM Friday May 10 2019 9:30AM 1 Belfast
Return Thursday Jun 6 2019 8:30AM Thursday Jun 6 2019 9:30AM 1 Belfast
Return Friday Jun 21 2019 8:30AM Friday Jun 21 2019 10:30AM 1 Belfast